Investor Presentaiton

Investor Presentation First nine months of 2018 The GLP-1 segment accounts for around 6% of the total diabetes care market in Region Latin America Region Latin America GLP-1 market VictozaⓇ value market share in Region Latin America GLP-1 value in bDKK VictozaⓇ Exenatide Dulaglutide Other 0.7 0.6 CAGR value¹: 9.3% 0.5 0.4 0.3 0.2 0.1 0.0 Aug 2013 1 CAGR for 5-year period Source: IQVIA monthly MAT Aug, 2018 value figures (DKK) changing diabetes® Share of total diabetes care market GLP-1 value market share 100% 1 6% 5% 80% 4% 60% - 3% 40% 2% 20% 1% 0% 0% Aug 2018 Aug 2013 Source: IQVIA monthly MAT Aug, 2018 value figures (DKK) Slide 82 VictozaⓇ Exenatide Dulaglutide Other 69% 30% 1% Aug 2018 novo nordisk

View entire presentation